The Guardian (Free subscription) | 22 hours ago
Bryn Williams was apprehensive when he first told his work colleagues he had Parkinson's disease last month. But their positive reaction has filled him with optimism for the future
Illinois Medical Malpractice Blog (Free subscription) | 07/24/2008
Pfizer and Boehringer-Ingelheim have been called before a federal court following a class action lawsuit for the negligent manufacture and distribution of Mirapex , a drug recently given to patients suffering from Parkinson’s disease and Restless Leg Syndrome . The lawsuit arose after two studies, one in 2003 by the Muhammad Ali Parkinson Research Center at Barrow Neurological Institute in Arizona...
Supercomputing Online (Free subscription) | 07/24/2008
GeForce GPU Runs Folding@home Protein Simulations 140 Times Faster Than Traditional Processors: Stanford University's distributed computing program Folding@home has become a major force in researching cures to life-threatening diseases such as cancer, cystic fibrosis, and Parkinson's disease by combining the computing horsepower of millions of processors to simulate protein folding. The Folding@home...
East Grinstead Courier (Free subscription) | 07/24/2008
A Woman from Copthorne who suffers from Parkinson's disease has had her book recorded to CD.
Times Online (Free subscription) | 07/23/2008
A close ally of the Pope has caused fury from Alzheimer's and Parkinson's Disease charities after comparing divisions in the Anglican Church with "spiritual Alzheimer's" and "ecclesial Parkinson's".
Red Orbit (Free subscription) | 07/23/2008
Depomed, Inc. (NASDAQ:DEPO) announced today that it has been awarded a preclinical grant by The Michael J. Fox Foundation under the foundation's Therapeutics Development Initiative 2008 Program.
Fight Aging! (Free subscription) | 07/23/2008
You might recall that the chemical alpha-synuclein is an aggregate that appears to be a proximate cause of Parkinson's disease (and like many biochemical aggregates, its buildup is slowed by the practice of calorie restriction). Researchers are delving deeper into the chain of mechanisms: Patients with Parkinson's disease (PD) have elevated levels of the protein called alpha-synuclein in their brains....
Medical News Today (Free subscription) | 07/22/2008
What does the genetics of blood cells have to do with brain cells related to Parkinson's disease? From an unusual collaboration of neurologists and a pharmacologist comes the surprising answer: Genetic mechanisms at play in blood cells also control a gene and protein that cause Parkinson's disease.
Market Wire (Free subscription) | 07/21/2008
TORONTO, ONTARIO (MARKET WIRE) As SuperWalk 2008 quickly approaches, walkers are working hard to raise $2.5 million! Parkinson Society Canada's (PSC) largest annual fundraiser takes place this September in 80 cities across Canada. With SuperWalk, PSC hopes to increase its support for research into areas such as the role of environmental toxins in Parkinson's.The goal is to eradicate Parkinson's altogether...
Science Daily (Free subscription) | 07/21/2008
What does the genetics of blood cells have to do with brain cells related to Parkinson's disease? From an unusual collaboration of neurologists and a pharmacologist comes the surprising answer: genetic mechanisms at play in blood cells also control a gene and protein that cause Parkinson's disease.
Daily Express (Free subscription) | 07/20/2008
HOLLYWOOD actor Michael J Fox is making a comeback to the screen after doctors told him his Parkinson's disease is medically controlled enough for him to work again.
Medical News Today (Free subscription) | 07/19/2008
The Michael J. Fox Foundation for Parkinson's Research has announced approximately $2.4 million in total funding to nine research teams under its Target Validation initiative. This annual MJFF program provides intellectual and financial resources to help push potential PD drug targets forward toward clinical trials and ultimately the nearly five million Parkinson's patients worldwide.
kansascity.com (Free subscription) | 07/18/2008
CHICAGO | When Tammy Rothwell started taking a prescription drug called Mirapex for the symptoms of her Parkinson’s disease, she thought she had finally found peace after 25 years.
Red Orbit (Free subscription) | 07/17/2008
NEW YORK, July 17 /PRNewswire-USNewswire/ -- The Michael J. Fox Foundation for Parkinson's Research today announced approximately $2.4 million in total funding to nine research teams under its Target Validation initiative.
PR News Wire (Free subscription) | 07/17/2008
NEW YORK, July 17 /PRNewswire-USNewswire/ -- The Michael J. Fox Foundation for Parkinson's Research today announced approximately $2.4 million in total funding to nine research teams under its Target Validation initiative. This annual MJFF program provides intellectual and financial resources to help push potential PD drug targets forward toward clinical trials and ultimately the nearly five million...
The last article published by a user on Parkinson's Disease :
sunilnair | 12/26/2007
Stakeholder Opinions: Parkinson's Disease - Review of Key Commercial Opportunities in the Symptomatic Treatment Market Introduction Parkinson's disease (PD) is a progressive, degenerative condition of the central nervous system (CNS), caused by the degeneration of dopaminergic neurons in the substantia nigra of the midbrain. The PD market grew by 6.9% to $1.8 billion between 2004 and 2005. In the...
